ABBOTT LABORATORIES — Director's Dealing 2004

Apr 22, 2004

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2004-04-20

Reporting Person: NEMMERS JOSEPH M (Senior Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2004-04-20	Common shares without par value	M	15569	$35.36	Acquired	73140	Direct
2004-04-20	Common shares without par value	F	13684	$44.20	Disposed	59456	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2004-04-20	Option (right to buy)	$35.36	M	15569	Disposed	2013-02-13	common shares (15569)	Direct
2004-04-20	Option (right to buy)	$44.20	A	13684	Acquired	2013-02-13	common shares (13684)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	10388	Indirect
Common shares without par value	332	Indirect
Common shares without par value	332	Indirect
Common shares without par value	278	Indirect
Common shares without par value	272	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of April 20, 2004.

F2: Reporting person disclaims beneficial ownership of all securities held by his sons.

F3: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.

F4: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3.